Annual Revenue (£)
Smith & Nephew revenue was £3.46 b in FY, 2017
| FY, 1996 | FY, 1997 | FY, 1998 | FY, 1999 | FY, 2000 | FY, 2001 | FY, 2002 | FY, 2003 | FY, 2004 | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | £1.07 b | £1.05 b | £1.05 b | £1.12 b | £1.13 b | £1.08 b | £1.11 b | £1.18 b | £1.25 b | £1.41 b | £1.42 b | £2.04 b | £2.87 b | £3.17 b | £3.58 b | £3.39 b | £3.46 b |
| Growth | 10.53% | 0.37% | 13.47% |
Report incorrect company information
Annual Growth Rate (%)
Revenue Breakdown
Business Segment
Smith & Nephew revenue breakdown by business segment: 12.9% from Sports Medicine Joint Repair , 13.9% from Arthroscopic Enabling Technologies , 9.9% from Trauma & Extremities, 19.8% from Knee Implants, 12.9% from Hip Implants, 14.9% from Advanced Wound Care, 6.9% from Advanced Wound Bioactives and 8.9% from Other
| FY, 2016 | |
|---|---|
| Advanced Wound Devices | 4 |
| Sports Medicine Joint Repair | 13 |
| Arthroscopic Enabling Technologies | 14 |
| Trauma & Extremities | 10 |
| Other Surgical Businesses | 5 |
| Knee Implants | 20 |
| Hip Implants | 13 |
| Advanced Wound Care | 15 |
| Advanced Wound Bioactives | 7 |
Report incorrect company information
